Leap Therapeutics Inc (LPTX)
3.20
-0.09
(-2.74%)
USD |
NASDAQ |
Apr 25, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Leap Therapeutics Cash from Operations (TTM): -43.75M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -43.75M |
September 30, 2023 | -46.39M |
June 30, 2023 | -48.15M |
March 31, 2023 | -50.23M |
December 31, 2022 | -49.04M |
September 30, 2022 | -46.75M |
June 30, 2022 | -42.60M |
March 31, 2022 | -38.09M |
December 31, 2021 | -35.16M |
September 30, 2021 | -30.43M |
June 30, 2021 | -28.92M |
March 31, 2021 | -30.62M |
December 31, 2020 | -25.96M |
September 30, 2020 | -25.86M |
June 30, 2020 | -26.23M |
March 31, 2020 | -23.96M |
December 31, 2019 | -26.90M |
September 30, 2019 | -28.06M |
June 30, 2019 | -28.55M |
March 31, 2019 | -27.42M |
December 31, 2018 | -26.03M |
Date | Value |
---|---|
September 30, 2018 | -25.35M |
June 30, 2018 | -20.26M |
March 31, 2018 | -21.27M |
December 31, 2017 | -22.14M |
September 30, 2017 | -23.06M |
June 30, 2017 | -28.08M |
March 31, 2017 | -27.55M |
December 31, 2016 | -25.34M |
September 30, 2016 | -9.496M |
June 30, 2016 | -7.487M |
March 31, 2016 | -6.593M |
December 31, 2015 | -8.102M |
September 30, 2015 | -22.30M |
June 30, 2015 | -22.05M |
March 31, 2015 | -20.72M |
December 31, 2014 | -18.02M |
September 30, 2014 | -16.16M |
June 30, 2014 | -12.99M |
March 31, 2014 | -11.08M |
December 31, 2013 | -9.939M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-50.23M
Minimum
Mar 2023
-23.96M
Maximum
Mar 2020
-35.56M
Average
-30.62M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
Cutera Inc | -120.89M |
OrthoPediatrics Corp | -27.05M |
AIM ImmunoTech Inc | -21.27M |
Protalix BioTherapeutics Inc | -1.318M |
Armata Pharmaceuticals Inc | -47.42M |